Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Garver

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
The American Journal of Psychiatry|January 1, 1975
A schizophreniform behavioral psychosis mediated by dopamineD L Garver, R F Schlemmer, J W Maas, et al.
Psychiatry Research|March 1, 1984
Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium responseR J Hitzemann, F Sautter, B Hitzemann, et al.
Psychological Medicine|November 1, 1988
Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias)D L Garver, K Kelly, K A Fried, et al.
Clinical Pharmacy|May 1, 1983
Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point methodM A Marr, P E Djuric, W A Ritschel, et al.
Psychopharmacology|January 1, 1984
Dopamine and non-dopamine psychosesD L Garver, F Zemlan, J Hirschowitz, et al.
The American Journal of Psychiatry|March 1, 1977
Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazineD L Garver, H Dekirmenjian, J M Davis, et al.
Biochemical Pharmacology|July 15, 1976
Effect of carbidopa on the metabolism of L-dopa in the pigtail monkeyR L Bronaugh, G R Wenger, D L Garver, et al.
Biological Psychiatry|January 15, 1990
Enlargement of cerebral third ventricle in psychotic patients with delayed response to neurolepticsM J Kaplan, M Lazoff, K Kelly, et al.
Schizophrenia Research|December 16, 1998
CSF N-CAM in neuroleptic-naïve first-episode patients with schizophreniaM P Vawter, J J Hemperly, W J Freed, et al.
Psychopharmacology|January 1, 1984
Adrenergic-receptor desensitization and course of clinical improvement with desipramine treatmentM L Mavroidis, D R Kanter, D N Greenblum, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
The American Journal of Psychiatry|January 1, 1975
A schizophreniform behavioral psychosis mediated by dopamineD L Garver, R F Schlemmer, J W Maas, et al.
Psychiatry Research|March 1, 1984
Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium responseR J Hitzemann, F Sautter, B Hitzemann, et al.
Psychological Medicine|November 1, 1988
Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias)D L Garver, K Kelly, K A Fried, et al.
Clinical Pharmacy|May 1, 1983
Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point methodM A Marr, P E Djuric, W A Ritschel, et al.
Psychopharmacology|January 1, 1984
Dopamine and non-dopamine psychosesD L Garver, F Zemlan, J Hirschowitz, et al.
The American Journal of Psychiatry|March 1, 1977
Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazineD L Garver, H Dekirmenjian, J M Davis, et al.
Biochemical Pharmacology|July 15, 1976
Effect of carbidopa on the metabolism of L-dopa in the pigtail monkeyR L Bronaugh, G R Wenger, D L Garver, et al.
Biological Psychiatry|January 15, 1990
Enlargement of cerebral third ventricle in psychotic patients with delayed response to neurolepticsM J Kaplan, M Lazoff, K Kelly, et al.
Schizophrenia Research|December 16, 1998
CSF N-CAM in neuroleptic-naïve first-episode patients with schizophreniaM P Vawter, J J Hemperly, W J Freed, et al.
Psychopharmacology|January 1, 1984
Adrenergic-receptor desensitization and course of clinical improvement with desipramine treatmentM L Mavroidis, D R Kanter, D N Greenblum, et al.
Pageof 10